Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.2.1.7 (
BAL
)
1,977
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We evaluated the levels of
bradykinin
, albumin, TAME-esterase activity, histamine, PGD2 and LTC4 in bronchoalveolar lavage fluid from asthmatics and from patients with pneumonia, sarcoidosis, fibrosis, and chronic bronchitis. Compared with the results of healthy volunteers and atopic asymptomatic asthmatics the
bradykinin
levels and TAME-esterase activity were significantly elevated. In all other groups, histamine was additionally elevated in asymptomatic asthmatics, whereas albumin was elevated in symptomatic asthmatics and fibrosis patients, and decreased in chronic bronchitis and pneumonia patients. Following local intrabronchial allergen challenge of mild grass pollen asthmatics out of season
bradykinin
levels increased significantly, correlated with albumin, histamine and TAME-esterase activity. In contrast to the increased mediator concentrations in the early phase reaction there was no change of
BAL
cells in asthmatics compared to baseline and healthy volunteers. The presence of
bradykinin
in the bronchoalveolar space of patients with active pulmonary inflammations and
bradykinin
generation in asthmatics as a result of intrabronchial allergen challenge provides strong evidence that kinins are involved in inflammatory disorders of the lower airways.
...
PMID:Bradykinin and other inflammatory mediators in BAL-fluid from patients with active pulmonary inflammation. 146 81
Bronchial tissue kallikrein is the major kininogenase activity in the airways of asthmatic subjects. The relationship of IgE-mediated events to its release and/or activation is unknown, however, and is the subject of this report. Seven subjects with mild atopic asthma underwent endobronchial challenge with relevant aeroallergen. Baseline pre-allergen lavage and sequential post-challenge lavages were collected over an approximate 10-minute time course. Individual aliquots were analyzed separately and compared with saline control lavages performed in a separate lobe. In five of the seven subjects, an increase in tissue kallikrein activity, measured by cleavage of the synthetic substrate Val-Leu-Arg-pNA, was identified in the post-challenge lavages. The antigenic identity of the enzymatic activity was confirmed as a tissue kallikrein in each case by immunoblotting. Tissue kallikrein activity was highly correlated with the appearance of immunoreactive histamine and kinin (p = 0.0001). High molecular weight
kininogen
influx and cleavage was detected in the post-challenge samples by immunoblotting and paralleled the detection of kinin in
BAL
fluid. Two of the subjects, despite clinical profiles similar to those of the five positive responders, failed to react to endobronchial challenge. Saline control lavages contained detectable kallikrein, kinin, and histamine in two subjects; in each case, however, this was significantly less than in the post-allergen samples. The results demonstrate a close association between immediate type hypersensitivity events in the lower airway and the appearance of active kallikrein,
kininogen
substrate, and the liberation of kinin.
...
PMID:Elevation of tissue kallikrein and kinin in the airways of asthmatic subjects after endobronchial allergen challenge. 155 19
Angiotensin converting enzyme (ACE) is present in the endothelial cells of the normal lung where it converts angiotensin I to angiotensin II and inactivates
bradykinin
. It has been suggested that during endothelial injury ACE is sloughed into the blood, and that if the alveolar capillary membrane is injured, also into the alveolar lining fluid. Seven patients with adult respiratory distress syndrome (ARDS), were compared to 11 normal control subjects, nine patients with sarcoidosis, and six with idiopathic pulmonary fibrosis. Total, differential cell counts and ACE determinations were performed on bronchoalveolar lavage fluid in the ARDS group. ACE was detectable in the
BAL
of all but one ARDS patient. It was concluded that
BAL
ACE is elevated in some ARDS patients, especially those with infectious causes of lung injury. Increased ACE may reflect endothelial damage or local increase in ACE production in response to sepsis.
...
PMID:Angiotensin converting enzyme in bronchoalveolar lavage in ARDS. 302 28
BPF and
BAL
inhibited kininase activity of homogenates of rat intestine. However, BFP potentiated and
BAL
inhibited the contractions induced by
bradykinin
on rat isolated duodenum (low calcium solution) and terminal ileum (normal calcium solution). Neither BPF nor
BAL
affects the relaxation induced by
bradykinin
of rat duodenum bathed in normal Tyrode. These results suggest that two different types of pharmacological receptor are involved in the action of
bradykinin
on rat intestine, and that other factors besides the inhibition of agonist destruction participate in the mechanism of potentiation of kinin action by BPF.
...
PMID:Action of bradykinin potentiating factor (BPF) and dimercaprol (BAL) on the responses to bradykinin of isolated preparations of rat intestines. 509 Nov 64
In 14 patients with sarcoidosis and in 9 healthy controls the
bradykinin
level was estimated in broncho-alveolar lavage fluid. The statistically significantly higher
bradykinin
concentrations was found in sarcoid patients than in controls. No relationship was found between level of
bradykinin
in
BAL
and lymphocytes % and no relationship was found between
bradykinin
level and pulmonary function parameters.
...
PMID:[Bradykinin levels in BAL fluid in patients with sarcoidosis]. 863 Apr 67